Prognostic Relevance of <i>NPM1</i> and <i>FLT3</i> Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience
The prognosis of acute myeloid leukemia depends on genetic aberrations, particularly <i>NPM1</i> and <i>FLT3</i>-ITD mutations. The targeted drugs’ availability has renewed interest in <i>FLT3</i> mutations, but the impact of these genetic alterations using these...
Main Authors: | Erika Borlenghi, Chiara Cattaneo, Diego Bertoli, Elisa Cerqui, Silvana Archetti, Angela Passi, Margherita Oberti, Tatiana Zollner, Carlotta Giupponi, Chiara Pagani, Nicola Bianchetti, Chiara Bottelli, Samuele Bagnasco, Margherita Sciumè, Alessandra Tucci, Giuseppe Rossi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/19/4716 |
Similar Items
-
The Role of Nucleophosmin 1 (<i>NPM1</i>) Mutation in the Diagnosis and Management of Myeloid Neoplasms
by: Katalin Kelemen
Published: (2022-01-01) -
The Impact of Mutation of Myelodysplasia-Related Genes in De Novo Acute Myeloid Leukemia Carrying <i>NPM1</i> Mutation
by: Yi Wang, et al.
Published: (2022-12-01) -
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia
by: Fabio Forghieri, et al.
Published: (2021-08-01) -
<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
by: Fabio Forghieri, et al.
Published: (2020-11-01) -
Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia
by: Young Hoon Park, et al.
Published: (2022-07-01)